Journal: Redox Biology
Article Title: Neutrophil Irgm1 ameliorates sepsis-induced myocardial dysfunction by promoting Alox15 degradation
doi: 10.1016/j.redox.2026.104104
Figure Lengend Snippet: Administration of PD146176 can eliminate the detrimental effects caused by Irgm1 deficiency in vivo . (A) Schematic illustration of PD146176 treatment in Irgm1-cKO mice. The mice were intraperitoneally injected with PD146176 (10 mg/kg). (B) Graphs showing the levels of 15-HETE in the serum of Irgm1-cKO mice given Vehicle or PD146176 after CLP (n = 5 per group). (C) Survival analysis of Irgm1-cKO mice given Vehicle (n = 24) or PD146176 (n = 18) after CLP performance was monitored for 24h. (D) Representative M-mode echocardiograms obtained from Irgm1-cKO mice given Vehicle or PD146176 after CLP. Scale bars = 2 mm (vertical) and 0.1 s (horizontal). (E-H) Echocardiographic measurements of left ventricular ejection fraction (EF, E), fractional shortening (FS, F), left ventricular internal diastolic dimension (LVIDD, G), and left ventricular end-diastolic volume (LVEDV, H) of Irgm1-cKO mice given Vehicle or PD146176 after CLP (n = 8 per group). Scale bars = 2 mm (vertical) and 0.1 s (horizontal). (I) Representative images of H&E staining and quantitative analysis of myocardial injury. Scale bars: 100 μm for high magnification, 500 μm for low magnification. (J and K) Graphs showing the levels of LDH (J) and cTnI (K) in the serum of Irgm1-cKO mice given Vehicle or PD146176 after CLP (n = 5 per group). (L) Relative ANP and BNP mRNA expression levels of the cardiac in Irgm1-cKO mice given Vehicle or PD146176 after CLP (n = 5 per group). (M) Relative mRNA expression levels of cardiac inflammation-related genes in Irgm1-cKO mice given Vehicle or PD146176 after CLP (n = 5 per group). (N) TUNEL staining and quantification of apoptotic cardiomyocytes in heart tissues from Irgm1-cKO mice given Vehicle or PD146176 after CLP (n = 5 per group). Scale bar = 20 μm. (O) Representative TEM images of heart sections from Irgm1-cKO mice given Vehicle or PD146176 after CLP. Scale bars: 0.5 μm for high magnification, 1 μm for low magnification. Data are represented as the mean ± SD. Log-rank test for C. Unpaired Student t -test for B, and E through N. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001; ∗∗∗∗ p < 0.0001.
Article Snippet: For pharmacological interventions, PD146176 (Alox15 inhibitor; 10 mg/kg, HY-103157, MedChemExpress) or 15-HETE (Arachidonic acid metabolites; 0.5 mg/kg, sc-200944, Santa Cruz Biotechnology) was administered intraperitoneally 15 min before CLP.
Techniques: In Vivo, Injection, Staining, Expressing, TUNEL Assay